Open AccessGalactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects
Author(s) -
Mingrong Cheng,
Qing Li,
Tao Wan,
Bing He,
Jing Han,
Houxiang Chen,
Yang Fengxiao,
Wei Wang,
Xu Hu,
Tao Ye,
Bingbing Zha
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i42.6076
Subject(s) - chemistry , apoptosis , cytotoxicity , flow cytometry , microbiology and biotechnology , liver cancer , cell cycle , pharmacology , in vitro , biochemistry , biology , cancer research , hepatocellular carcinoma
To observe the curative effect of galactosylated chitosan (GC)/5-fluorouracil (5-FU) nanoparticles in liver caner mice and its side effects.